BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3533643)

  • 1. Design and synthesis of multisubstrate analog inhibitors of one-carbon transfer reactions.
    Broom AD
    Fed Proc; 1986 Nov; 45(12):2779-83. PubMed ID: 3533643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of potent thymidylate synthase X inhibitors.
    Esra Onen F; Boum Y; Jacquement C; Spanedda MV; Jaber N; Scherman D; Myllykallio H; Herscovici J
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3628-31. PubMed ID: 18513963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT).
    Springer CJ; Bavetsias V; Jackman AL; Boyle FT; Marshall D; Pedley RB; Bisset GM
    Anticancer Drug Des; 1996 Dec; 11(8):625-36. PubMed ID: 9022750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
    Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
    J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzoyl ring halogenated classical 2-amino-6-methyl-3,4-dihydro-4-oxo-5-substituted thiobenzoyl-7H-pyrrolo[2,3-d]pyrimidine antifolates as inhibitors of thymidylate synthase and as antitumor agents.
    Gangjee A; Jain HD; McGuire JJ; Kisliuk RL
    J Med Chem; 2004 Dec; 47(27):6730-9. PubMed ID: 15615522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumour activity of fluorinated 1-aza and 1,8-diazaanthraquinones.
    Ramos MT; Díaz-Guerra LM; García-Copín S; Avendaño C; García-Grávalos D; García de Quesada T
    Farmaco; 1996 May; 51(5):375-9. PubMed ID: 8767848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimetabolic properties of 4,5-substituted pyrimidine 2'-deoxynucleosides and their 5'-monophosphates.
    Kulikowski T; Bretner M; Dzik JM; Zieliński Z; Cieśla J; Rode W; Vilpo JA; Shugar D
    Nucleic Acids Symp Ser; 1987; (18):61-4. PubMed ID: 3697152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Marriott JH; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1997 May; 40(10):1495-510. PubMed ID: 9154971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads.
    Singh P; Kaur M; Verma P
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3054-8. PubMed ID: 19398334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family.
    Ferrari S; Losasso V; Costi MP
    ChemMedChem; 2008 Mar; 3(3):392-401. PubMed ID: 18270995
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfamide antifolates inhibiting thymidylate synthase: synthesis, enzyme inhibition and cytotoxicity.
    Pawełczak K; Makowski M; Kempny M; Dzik JM; Gołos B; Rode W; Rzeszotarska B
    Acta Biochim Pol; 2002; 49(2):407-20. PubMed ID: 12362982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidylate synthase inhibitors.
    Touroutoglou N; Pazdur R
    Clin Cancer Res; 1996 Feb; 2(2):227-43. PubMed ID: 9816165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
    Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
    Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamation.
    Jackman AL; Kimbell R; Brown M; Brunton L; Bisset GM; Bavetsias V; Marsham P; Hughes LR; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):573-89. PubMed ID: 7495480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of protein structure-based drug design to cancer chemotherapy.
    Jackson RC
    Semin Oncol; 1997 Apr; 24(2):164-72. PubMed ID: 9129687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents.
    Benassi L; Magnoni C; Giudice S; Bertazzoni G; Costi MP; Rinaldi M; Venturelli A; Coppi A; Rossi T
    Anticancer Res; 2006; 26(5A):3499-504. PubMed ID: 17094473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
    Chu E; Callender MA; Farrell MP; Schmitz JC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.